BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
DTSTAMP:20260617T064630Z
CREATED:20260617T064630Z
LAST-MODIFIED:20260617T064630Z
UID:10628-1790726400-1790812799@thebiocalendar.com
SUMMARY:Biocom’s HR Conference for Life Science
DESCRIPTION:Biocom invites you to attend our HR Conference for Life Science held in-person on September 30 at The Alexandria Torrey Pines in San Diego. Join us to form meaningful connections\, elevate your practices as a human resources leader and gain the tools and insights needed to create a positive\, lasting impact within organizations of all sizes.
URL:https://thebiocalendar.com/event/biocoms-hr-conference-for-life-science/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261002
DTSTAMP:20260516T073832Z
CREATED:20260506T134840Z
LAST-MODIFIED:20260516T073832Z
UID:10384-1790726400-1790899199@thebiocalendar.com
SUMMARY:Life Sciences Future
DESCRIPTION:Life Sciences Future is the annual meeting of the Pennsylvania life sciences ecosystem. From biotechnology\, medical device and diagnostics\, pharmaceuticals to research institutions\, investment organizations\, and strategic advisors\, all key stakeholders will gather September 30- October 1\, 2026 in King of Prussia\, this year with a prime focus on strategic partnering. \nAttendees will hear large company and investor reverse pitch presentations to learn what global pharma and device organizations are looking to add to their portfolios; receive access to the exclusive online partnering system to schedule in-person meetings with key strategic partners; and will learn best practices through panels and interactive discussions for building and strengthening connections to grow your business. \nHelp plan LSPA’s largest partnering event of the year and join a planning committee. Once you register at the discounted rate\, you will be prompted to select your committee preferences.
URL:https://thebiocalendar.com/event/life-sciences-future-4/
LOCATION:King of Prussia\, PA\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:Annual Meeting,Featured
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/05/af-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261002
DTSTAMP:20260504T222233Z
CREATED:20260504T222233Z
LAST-MODIFIED:20260504T222233Z
UID:10341-1790640000-1790899199@thebiocalendar.com
SUMMARY:BIOSPAIN 2026
DESCRIPTION:BIOSPAIN is one of the largest biotech events organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 30% of our delegates came from outside of Spain. Also\, of the 287 exhibitors\, 32% were international. \nThis year\, BIOSPAIN will be held in Bilbao\, one of the main biotech cluster in Spain and One of Spain’s most avant-garde cities. \nThe event will take place in Pavillion 2\, Bilbao Exhibition Cente\, located in Barakaldo\, less then 20 minutes from downtown Bilbao\, it is one of the most modern and largest trade-show complexes in Europe.
URL:https://thebiocalendar.com/event/biospain-2026/
LOCATION:Bilbao\, Bilbao\, Spain
CATEGORIES:Networking,Partnering,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260928
DTEND;VALUE=DATE:20261002
DTSTAMP:20260721T185928Z
CREATED:20260528T101402Z
LAST-MODIFIED:20260721T185928Z
UID:10528-1790553600-1790899199@thebiocalendar.com
SUMMARY:Discovery on Target
DESCRIPTION:Discovery on Target brings together the science\, technology\, and people driving the future of drug discovery. For more than 20 years\, the meeting has showcased breakthroughs shaping therapeutic innovation across small molecules\, antibodies\, and emerging modalities—including peptides\, conjugates\, and radiopharmaceuticals. \nAcross four days and seven concurrent tracks\, 1\,000+ attendees explore advances in target discovery\, lead generation\, screening technologies\, AI/ML\, and next-generation biologics—while connecting through presentations\, exhibits\, posters\, and interactive sessions designed to spark collaboration and move discovery forward.
URL:https://thebiocalendar.com/event/dot26/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Networking,Presentation,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260923
DTSTAMP:20260709T104235Z
CREATED:20260709T104235Z
LAST-MODIFIED:20260709T104235Z
UID:10752-1790035200-1790121599@thebiocalendar.com
SUMMARY:Life Sciences Product Launch Summit
DESCRIPTION:The Life Sciences Product Launch Summit is a premier event designed to empower professionals in pharma and biotech commercialization with the tools and strategies needed to craft the ultimate launch playbook. This summit is essential for navigating the complexities of product launches in a dynamic and competitive marketplace. Attendees will gain exclusive insights into creating a comprehensive playbook that addresses critical aspects such as market access hurdles\, innovative pricing strategies and aligning portfolio strategies with unmet market needs.
URL:https://thebiocalendar.com/event/life-sciences-product-launch-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260926
DTSTAMP:20260324T074733Z
CREATED:20260324T074629Z
LAST-MODIFIED:20260324T074733Z
UID:10064-1790035200-1790380799@thebiocalendar.com
SUMMARY:Biotech Week Boston 2026
DESCRIPTION:Be a Part of the Conversation at Biotech Week Boston 2026\n\n\n\n\n\nConnect with the full biopharmaceutical ecosystem – Biotech\, Academia\, Investors and Service Providers\nWhere C-Suite and Science come together to drive business and innovation\n3200+ global attendees from 35 countries under one roof
URL:https://thebiocalendar.com/event/biotech-week-boston-2026/
LOCATION:Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260915
DTEND;VALUE=DATE:20260917
DTSTAMP:20260721T185754Z
CREATED:20260721T185408Z
LAST-MODIFIED:20260721T185754Z
UID:10831-1789430400-1789603199@thebiocalendar.com
SUMMARY:16th Annual DPHARM
DESCRIPTION:Connecting 1\,000+ Industry Executives\, Innovators\, and Change-Makers \n\n\n\n\n\n\n\n\nThe 16th Annual DPHARM® will offer an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations on modernizing clinical trials. \nDPHARM speakers report on R&D industry innovation that drives greater efficiencies and accelerates clinical trials for the benefit of patients. \nDPHARM 2026 features senior clinical operation executives with industry and patient thought leadership\, and technologists showcasing the latest innovations in clinical trials driving efficiencies in operational processes and reducing patient\, site and physician burden to participating in research.​​​​​​​
URL:https://thebiocalendar.com/event/16th-annual-dpharm/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260915
DTSTAMP:20260721T185250Z
CREATED:20260721T185249Z
LAST-MODIFIED:20260721T185250Z
UID:10829-1789344000-1789430399@thebiocalendar.com
SUMMARY:Partnerships with Sites Summit
DESCRIPTION:How can sponsors\, CROs\, and sites adapt to improve enrollment and retention in a changing clinical trial environment?  \n\n\n\n\n\n\n\n\n\nThe Partnerships with Sites Summit challenges how sponsors\, CROs\, and sites adapt to a rapidly evolving clinical trial ecosystem shaped by shifts in the global site landscape\, increasing study complexity\, evolving technology\, and changing operating models. These forces are reshaping clinical trial execution and placing new demands on consistency\, coordination\, and performance across the system. \n\n\nAs the role of sites continues to evolve\, the summit brings stakeholders together to rethink how trials are designed and executed in this new environment—where execution determines enrollment and retention outcomes. \n\n\nThe summit focuses on the key forces shaping this inflection point:  \n\n\n\nIncreasing variability across site types is challenging consistent trial execution\n\n\n\n\nRising protocol complexity and operational demands are straining coordination and site capacity\n\n\n\n\nFragmented technology adoption is creating workflow inefficiencies across studies and systems\n\n\n\n\nMisaligned operating models are driving variability in startup timelines\, delivery\, and performance outcomes\n\n\n\n\nEarlier alignment on study design\, governance\, and execution expectations is becoming critical to improving feasibility and consistency
URL:https://thebiocalendar.com/event/partnerships-with-sites-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260917
DTSTAMP:20260727T213626Z
CREATED:20260701T193131Z
LAST-MODIFIED:20260727T213626Z
UID:10725-1789344000-1789603199@thebiocalendar.com
SUMMARY:AGBT Precision Health Meeting
DESCRIPTION:AGBT Precision Health\, taking place September 14-16\, 2026\, at the Loews Coronado Bay Resort\, San Diego\, California\, brings together leaders across genomics\, healthcare\, AI\, and biotechnology to explore how emerging technologies are transforming precision medicine and clinical care. \n\n\n  \n\n\nWhy Attend? \n\nConnect with researchers\, clinicians\, industry innovators\, investors\, and policymakers in intimate networking settings designed to encourage conversation and exchange of ideas.\nLearn from leading voices across genomics\, including Niall Lennon\, recipient of a GUINNESS WORLD RECORDS™ title for the fastest DNA sequencing technique.\nExplore new collaborations\, partnerships\, and business opportunities.\n\nAbstract Submissions and Next Gen Leadership Awards \nResearchers are invited to submit cutting-edge work across precision health\, genomics\, AI\, diagnostics\, rare disease\, translational medicine\, and related fields. Selected abstracts may be featured as poster presentations\, flash talks\, and oral presentations throughout the meeting program. \nWe also encourage graduate students\, postdoctoral researchers\, and other early-career professionals to apply for the AGBT Next Gen Leadership Award Program. Selected participants will receive travel support\, hotel accommodations\, and complimentary registration. \nSponsorship and Exhibitor Opportunities \nAGBT Precision Health provides direct access to a highly engaged audience of scientific leaders\, clinicians\, healthcare innovators\, and industry decision-makers driving the future of precision medicine. Increase brand visibility\, showcase innovations\, and connect with key decision-makers. \nKey Dates to keep in mind: \n\nAbstract Submission Deadline: July 21\, 2026\nNext Gen Leadership Award applications close: July 21\, 2026\nEarly Bird Rates Close: August 3rd\, 2026\n\nIf you’re considering attending\, submitting an abstract\, or exploring sponsorship or exhibitor opportunities\, click on this link: https://www.agbtprecisionhealth.org
URL:https://thebiocalendar.com/event/the-2026-agbt-precision-health-meeting/
LOCATION:Loews Coronado Bay Resort\, 4000 Coronado Bay Road\, Coronado\, 92118\, United States
CATEGORIES:Forum,Summit,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260918
DTSTAMP:20260617T130743Z
CREATED:20260617T130743Z
LAST-MODIFIED:20260617T130743Z
UID:10629-1789344000-1789689599@thebiocalendar.com
SUMMARY:Fierce Pharma Week
DESCRIPTION:Fierce Pharma Week is a major annual conference and networking event for the life sciences industry\, produced by Fierce Pharma. It brings together thousands of pharmaceutical and biotech decision-makers—including C-suite executives\, marketing leaders\, PR teams\, and medical affairs professionals—to shape the future of commercial\, scientific\, and communications strategies.
URL:https://thebiocalendar.com/event/fierce-pharma-week/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260916
DTSTAMP:20260504T222100Z
CREATED:20260504T222100Z
LAST-MODIFIED:20260504T222100Z
UID:10340-1789344000-1789516799@thebiocalendar.com
SUMMARY:Drug Delivery & Formulation Summit
DESCRIPTION:The 16th American Drug Delivery & Formulation will once again bring together an exceptional line-up of the industry’s best speakers\, with technical experts\, industry leaders\, and specialists providing an unmissable two days of the latest information. \nNow in its 16th year\, the summit continues to go from strength to strength. Last year saw a record number of attendees with over 450 scientific leaders from pharma\, biotech\, and drug delivery industries. \nThose in attendance will benefit from a packed two-day programme\, where they will explore the critical issues with the industry’s best speakers. There will be plentiful networking times\, expect to meet fellow industry leaders\, enabling meetings\, connections\, and business growth.
URL:https://thebiocalendar.com/event/drug-delivery-formulation-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260903
DTSTAMP:20260709T104118Z
CREATED:20260709T104118Z
LAST-MODIFIED:20260709T104118Z
UID:10750-1788220800-1788393599@thebiocalendar.com
SUMMARY:Hubs West
DESCRIPTION:The Hub and Specialty Pharmacy Model conference series returns to sunny San Diego\, CA at the stunning Estancia La Jolla Hotel & Spa. Demand for agile\, scalable and innovative programs are at an all time high as market dynamics continue to evolve and regulatory changes remains unclear. This event brings together top industry experts to equip you with cutting-edge technologies and actionable insights to enhance patient outcomes. Hub and Specialty Pharmacy Models West is the premier event for professionals seeking unparalleled networking opportunities and expert-driven content to refine their hub strategies and elevate their patient services suite.
URL:https://thebiocalendar.com/event/hubs-west/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Networking,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260831
DTEND;VALUE=DATE:20260901
DTSTAMP:20260504T221917Z
CREATED:20260504T221917Z
LAST-MODIFIED:20260504T221917Z
UID:10339-1788134400-1788220799@thebiocalendar.com
SUMMARY:ESC Congress 2026
DESCRIPTION:Join us and experience transformation through practice\, policy\, responsibility and genuine human connection. \nThis year’s Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot\, enhancing precision\, speed\, and safety in patient care. Discover AI in action\, from diagnosis to delivery\, through hands-on sessions\, live demonstrations\, and immersive learning. \nHere we will explore a diverse range of topics\, uniting all subspecialties to create a space to share breakthrough data and debate new ideas\, before applying innovation to real-world settings. \nThis is where collaboration becomes progress\, and transformation is not just seen\, but felt.
URL:https://thebiocalendar.com/event/esc-congress-2026/
LOCATION:Munich\, Munich\, Bavaria\, Germany
CATEGORIES:Seminar,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T100000
DTEND;TZID=America/Los_Angeles:20260827T110000
DTSTAMP:20260728T181700Z
CREATED:20260728T181700Z
LAST-MODIFIED:20260728T181700Z
UID:10883-1787824800-1787828400@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update: CPHI Milan 2026 Special Edition
DESCRIPTION:Are you making the most of your time at CPHI Milan? \nWatch this free virtual event to evaluate CDMOs\, CMOs\, API suppliers\, packaging providers\, and other outsourcing partners before you arrive onsite. Gain early insight into supplier capabilities\, compare potential partners\, and build a focused meeting strategy that maximizes your time at CPHI Milan. \nRegister today to identify the right partners\, prioritize high-value conversations\, and arrive in Milan ready to make informed outsourcing decisions.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-cphi-milan-2026-special-edition/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-27.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260826T110000
DTEND;TZID=America/Los_Angeles:20260826T120000
DTSTAMP:20260725T054932Z
CREATED:20260720T125405Z
LAST-MODIFIED:20260725T054932Z
UID:10801-1787742000-1787745600@thebiocalendar.com
SUMMARY:Controlling UF/DF with Confidence: How to Define\, Monitor\, and Hit Critical Endpoints
DESCRIPTION:A practical framework for reducing variability\, minimizing manual sampling\, and improving run-to-run consistency with modern UF/DF control strategies. \nAugust 26\, 2026 | 11:00 AM ET \nUltrafiltration Diafiltration (UF/DF) is often treated as a straightforward concentration and buffer-exchange step\, but teams know the reality looks different. Small differences in setup\, endpoint definition\, and in-process decision-making can create major run-to-run variability\, especially as programs move from process development into scale-up and manufacturing. \nIn this webinar\, we will focus on the practical question that determines whether UF/DF is repeatable and scalable: How do you define the right endpoints\, monitor them in real time\, and consistently hit them without relying on constant manual sampling and operator intervention? We will walk through a clear approach to selecting critical UF/DF endpoints (for concentration and diafiltration)\, connecting them to the right measurements\, and using in-line analytics to improve accuracy and consistency. \nKey topics include:\nWhat “critical endpoints” really mean in UF/DF\, and why unclear endpoints drive variability across runs and teams\nEndpoint selection made practical: choosing concentration and diafiltration endpoints that align with process goals and downstream requirements\nHow real-time\, in-line concentration data enables automated control\, reducing manual sampling and dilution while improving efficiency\, consistency\, and decision-making\nReducing variability across scales by linking endpoint definition\, monitoring strategy\, and execution consistency from PD through manufacturing\nTroubleshooting through the lens of control: how clearer endpoints and better monitoring help teams respond faster to instability and performance drift \nWhether you are building a UF/DF strategy in development\, preparing for tech transfer\, or tightening control in manufacturing\, this session will provide practical guidance for making UF/DF easier to run\, easier to scale\, and easier to reproduce.
URL:https://thebiocalendar.com/event/controlling-uf-df-with-confidence-how-to-define-monitor-and-hit-critical-endpoints/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-26-26-Repligen-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260826
DTEND;VALUE=DATE:20260828
DTSTAMP:20260727T152559Z
CREATED:20260727T152559Z
LAST-MODIFIED:20260727T152559Z
UID:10875-1787702400-1787875199@thebiocalendar.com
SUMMARY:MEDevice Boston
DESCRIPTION:MEDevice Boston\, by Informa\, brings together leading medical device OEMs\, startups\, and suppliers from New England and beyond into a MedTech event engineered to advance the industry. \nIntentionally designed for partner connections and supplier evaluation\, this two-day experience creates a focused environment where high-intent buyers and solution providers connect. Through curated networking\, hands-on learning\, and dynamic on-site features\, MEDevice Boston drives meaningful conversations\, strategic partnerships\, and the technologies shaping the next generation of medical devices.
URL:https://thebiocalendar.com/event/medevice-boston/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260825T110000
DTEND;TZID=America/Los_Angeles:20260825T120000
DTSTAMP:20260727T143248Z
CREATED:20260727T143248Z
LAST-MODIFIED:20260727T143248Z
UID:10870-1787655600-1787659200@thebiocalendar.com
SUMMARY:Driving Measurable Productivity Gains in CHO Cell Culture
DESCRIPTION:Achieving consistent upstream performance remains a critical challenge as bioprocesses become more complex and quality expectations continue to rise. From variability in raw materials to maintaining cell growth\, productivity\, and product quality across platforms\, process developers are under increasing pressure to build more robust and reliable manufacturing processes. \nJoin this webinar to explore practical strategies for optimizing upstream CHO cell culture performance through media component selection and process design. Through real-world application data and case studies spanning both monoclonal antibodies and emerging antibody modalities\, our experts will share insights into reducing variability\, improving process consistency\, and enhancing key cell culture outcomes. \nLearning Objectives:\n   ~ Understand the impact raw material variability can have on upstream process performance and product quality\n   ~ Explore approaches to improving consistency\, cell growth\, viability\, and productivity in CHO-based processes\n   ~ Review case studies demonstrating successful media optimization strategies across multiple antibody production workflows\n  ~  Gain practical insights to support media selection and upstream process development decisions
URL:https://thebiocalendar.com/event/driving-measurable-productivity-gains-in-cho-cell-culture/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-25-26-Thermo-Reg-1920x250-rev.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260824
DTEND;VALUE=DATE:20260827
DTSTAMP:20260511T225230Z
CREATED:20260511T225230Z
LAST-MODIFIED:20260511T225230Z
UID:10419-1787529600-1787788799@thebiocalendar.com
SUMMARY:Next Generation Dx Summit
DESCRIPTION:Breakthrough Tech. Expert Insights. Real-World Impact. \n\n400+ diagnostics professionals from across the industry\n120+ speakers leading innovation in clinical and molecular Dx\n6 highly focused tracks spanning emerging technologies and commercial strategy\nUnmatched networking with partners\, labs\, regulators\, and investors\nEmerging company spotlight with novel platform technologies\n\nNext Generation Dx Summit is where the diagnostics ecosystem converges to accelerate innovation and expand patient access \n\n\n\n\nGain the latest insights in: \n\nClinical implementation and validation of diagnostic technologies\nPoint-of-care innovation and at-home testing\nEarly detection and enhanced screening of single cancers and MCEDs\nAI\, digital\, and emerging applications in companion diagnostics\nAI in lab management\, testing\, clinical decision support\, and analysis
URL:https://thebiocalendar.com/event/next-generation-dx-summit-3/
LOCATION:Washington\, DC\, Washington\, DC\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260821T110000
DTEND;TZID=America/Los_Angeles:20260821T120000
DTSTAMP:20260728T181155Z
CREATED:20260728T181155Z
LAST-MODIFIED:20260728T181155Z
UID:10878-1787310000-1787313600@thebiocalendar.com
SUMMARY:Container Closure Integrity Testing: Selecting a Test Method for your Container System
DESCRIPTION:Join us for a practical discussion on selecting the right Container Closure Integrity Testing (CCIT) method for your container system. Learn how deterministic and probabilistic approaches compare\, understand the impact of package design and product characteristics on method selection\, and gain a risk-based framework for justifying your CCIT strategy to regulators.
URL:https://thebiocalendar.com/event/container-closure-integrity-testing-selecting-a-test-method-for-your-container-system/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-21-26-Pace-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T133000
DTSTAMP:20260725T054955Z
CREATED:20260721T181456Z
LAST-MODIFIED:20260725T054955Z
UID:10823-1787223600-1787232600@thebiocalendar.com
SUMMARY:BVS’ Biotech Community Event at One Alexandria Square\, San Diego
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event in the Tribute Garden at One Alexandria Square. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Lunch & Drinks: Enjoy a delicious lunch as you network and explore the vendor exhibits. \nWe are inviting all the tenants and all local life science researchers and entrepreneurs in the surrounding area to attend. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-one-alexandria-square-san-diego/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Trade Show
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/07/BVS-Biotech-Event-Flyer-08-20-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T120000
DTSTAMP:20260729T150317Z
CREATED:20260729T150317Z
LAST-MODIFIED:20260729T150317Z
UID:10888-1787223600-1787227200@thebiocalendar.com
SUMMARY:Where Precision Drives Progress: Meeting the Rising Complexity of Modern Clinical Trials
DESCRIPTION:Explore how leading teams are using trusted data and targeted AI to design\, plan\, and execute trials with the confidence today’s science requires.  \nLearning outcomes:\n– Understand what’s driving trial complexity\n– Design protocols with confidence using real data + AI\n– Select sites based on holistic drivers of outcomes; access\, experience and past performance\n– Rethink patient recruitment as the critical success factor\n– Align with evolving regulatory expectations (ICH GCP E6 R3)
URL:https://thebiocalendar.com/event/where-precision-drives-progress-meeting-the-rising-complexity-of-modern-clinical-trials/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-20-26-Citeline-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T120000
DTSTAMP:20260725T055023Z
CREATED:20260724T110739Z
LAST-MODIFIED:20260725T055023Z
UID:10851-1787223600-1787227200@thebiocalendar.com
SUMMARY:CAR-T for Relapsed/Refractory AML: From Discovery to First-in-Human Active Phase 1 Evaluation
DESCRIPTION:Join Dr. Marco Davila to explore a novel anti-CD83 CAR-T design for relapsed/refractory AML that overcomes myelosuppression barriers. Register for the live session. \nDeveloping effective Chimeric Antigen Receptor (CAR) T-cell therapies for Acute Myeloid Leukemia (AML) remains one of the most formidable frontiers in cellular immunotherapy. Unlike lymphoid malignancies where lineage-specific targets like CD19 or BCMA offer a clear therapeutic window\, AML presents a severe biological bottleneck. The vast majority of well-characterized myeloid antigens (such as CD33 or CD123) are shared with healthy hematopoietic stem and progenitor cells (HSPCs). Consequently\, conventional CAR-T approaches frequently induce prolonged\, life-threatening myelosuppression and bone marrow aplasia severely limiting their clinical utility. This webinar by Dr. Marco Davila will explore a paradigm-shifting strategy developed at Roswell Park Comprehensive Cancer Center that addresses this exact barrier: a novel CAR-T design targeting the CD83 antigen. \nOur discussion will center on the unique biology of CD83\, a protein highly expressed on malignant AML blasts but distinctively regulated in healthy tissues\, offering a pathway to selectively suppress leukemia cells while sparing critical progenitor stem cells. Moving from bench to bedside\, we will detail the rigorous process development and GMP manufacturing frameworks involved in generating this CAR-T cell therapy to be tested in clinic. Finally\, we will share insights into the initiation and objectives of the first-of-its-kind\, active Phase 1 clinical trial evaluating autologous anti-CD83 CAR-T cell infusions in patients with relapsed or refractory AML. Join us to discover how this dual-action architecture reshapes safety\, efficacy\, and translation benchmarks in the myeloid cell therapy space.
URL:https://thebiocalendar.com/event/car-t-for-relapsed-refractory-aml-from-discovery-to-first-in-human-active-phase-1-evaluation/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-20-26-Miltenyi-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T120000
DTSTAMP:20260725T055053Z
CREATED:20260717T115757Z
LAST-MODIFIED:20260725T055053Z
UID:10796-1787223600-1787227200@thebiocalendar.com
SUMMARY:FDA Engagement Strategies And Best Practices Amid Agency Changes
DESCRIPTION:How can life sciences companies developing new medicines engage the FDA successfully during a period of rapid changes in agency personnel and policies? \nShould companies adjust their agency communication strategies or ask new questions during meetings? Our deeply experienced panelists will discuss key changes at the FDA\, how companies can get the most out of agency interactions\, and strategies to lower risks and avoid regulatory surprises. \nRegister for free today and secure your spot for this important virtual event.
URL:https://thebiocalendar.com/event/fda-engagement-strategies-and-best-practices-amid-agency-changes/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/26_08-LSL-HTML-600x300-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260818T130000
DTEND;TZID=America/Los_Angeles:20260818T140000
DTSTAMP:20260725T055605Z
CREATED:20260721T180509Z
LAST-MODIFIED:20260725T055605Z
UID:10816-1787058000-1787061600@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update August 2026: Oral Solid Dose Formulation
DESCRIPTION:Oral solid dose programs can run into costly scale-up challenges when early formulation and process decisions aren’t built for long-term manufacturability. \nJoin leading CDMO experts on August 18 at 1:00 PM ET to explore how excipient selection\, granulation strategy\, particle engineering\, and process design can impact tech transfer\, validation\, and commercial manufacturing. \nRegister now to gain practical insights for evaluating CDMO capabilities\, identifying scale-up risks earlier\, and making more informed partner selection decisions.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-august-2026-oral-solid-dose-formulation/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-26.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260818T110000
DTEND;TZID=America/Los_Angeles:20260818T120000
DTSTAMP:20260725T055842Z
CREATED:20260721T180321Z
LAST-MODIFIED:20260725T055842Z
UID:10811-1787050800-1787054400@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update August 2026: Nanoparticles
DESCRIPTION:Nanoparticle programs can stall when early formulation choices fail to hold up through scale-up\, tech transfer\, and manufacturing. \nJoin leading CDMO experts on August 18 at 11:00 AM ET to learn how decisions around lipid or polymer selection\, particle engineering\, process design\, and manufacturability can impact downstream success. \nRegister now to gain practical insights that will help you evaluate CDMO approaches\, ask sharper formulation questions\, and reduce risk before nanoparticle challenges become costly development setbacks.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-august-2026-nanoparticles/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-25.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260818T110000
DTEND;TZID=America/Los_Angeles:20260818T120000
DTSTAMP:20260714T195850Z
CREATED:20260714T125327Z
LAST-MODIFIED:20260714T195850Z
UID:10775-1787050800-1787054400@thebiocalendar.com
SUMMARY:The Future of Cell Culture Media Development: Predictive Modeling and AI
DESCRIPTION:As biologics developers work to improve productivity\, reduce development timelines\, and manage manufacturing costs\, traditional media optimization approaches can become increasingly resource intensive. Predictive modeling is emerging as a complementary approach that can help integrate biological knowledge\, process data\, and artificial intelligence (AI) to support more efficient media development. \nIn this webinar\, Thermo Fisher Scientific specialists discuss how predictive modeling and AI are being applied to cell culture media development. Learn how computational modeling can help identify promising formulation strategies\, focus experimental efforts\, and support more informed development decisions while maintaining the critical role of scientific expertise. \nIn this session\, you will learn about:\n~ The emerging role of predictive modeling in cell culture media development\n~ How AI can help support formulation optimization\n~ The value of integrating biological\, analytical\, and process data\n~ How predictive modeling and scientific expertise can work together to inform development decisions \nKey topics include:\n~ Challenges with traditional media optimization approaches\n~ AI-guided formulation design and in silico modeling\n~ Human expertise in predictive model development and validation\n~ Cross-functional collaboration in AI-enabled media development\n~ Predictive modeling in biologics development \nDiscover how predictive modeling and AI are helping shape the future of cell culture media development by supporting more informed\, data-driven approaches to media optimization.
URL:https://thebiocalendar.com/event/the-future-of-cell-culture-media-development-predictive-modeling-and-ai/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-18-26-Thermo-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260818
DTEND;VALUE=DATE:20260828
DTSTAMP:20260725T054714Z
CREATED:20260724T211527Z
LAST-MODIFIED:20260725T054714Z
UID:10856-1787011200-1787875199@thebiocalendar.com
SUMMARY:The Matrix One West Coast MedTech Forum
DESCRIPTION:The Matrix One West Coast MedTech Forum is a free series of expert roundtables\, educational sessions and networking events taking place across California from 18 to 27 August 2026. Designed for professionals throughout the MedTech and life sciences community\, the programme brings together regulatory affairs\, quality\, engineering\, product\, digital health and business leaders. \nAttendees will explore some of the most important issues shaping medical device development\, including practical applications of AI\, regulatory submissions\, design control\, audit readiness\, quality management\, cloud connectivity\, cybersecurity and compliant product development. Events will take place across San Francisco\, Palo Alto\, Redwood City\, Los Angeles\, Irvine and San Diego\, featuring insights from industry experts\, legal specialists\, former FDA professionals and local MedTech leaders\, alongside valuable opportunities to connect with peers.
URL:https://thebiocalendar.com/event/the-matrix-one-west-coast-medtech-forum/
LOCATION:California (multiple locations)\, CA\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T130000
DTEND;TZID=America/Los_Angeles:20260813T140000
DTSTAMP:20260714T195655Z
CREATED:20260714T125112Z
LAST-MODIFIED:20260714T195655Z
UID:10770-1786626000-1786629600@thebiocalendar.com
SUMMARY:From Data to Decisions: AI and Multi-Omics for Cell Culture Development
DESCRIPTION:As biologics developers work to improve productivity\, maintain product quality\, and accelerate development timelines\, traditional optimization approaches can sometimes reach a point of diminishing returns. While cell culture processes generate vast amounts of biological and process data\, extracting actionable insights from that information remains a significant challenge. \nIn this webinar\, Thermo Fisher Scientific specialists discuss how the integration of multi-omics data\, artificial intelligence (AI)\, and deep cell culture expertise can help uncover the biological mechanisms driving process performance. Learn how AI-enabled analytics can support more informed decision-making\, identify optimization opportunities\, and accelerate media and process development. \nIn this session\, you will learn about:\n~ The role of multi-omics in understanding cell culture performance\n~ How AI is helping uncover biological drivers of productivity and quality\n~ Emerging applications of predictive modeling in media and process development\n~ New approaches to turning complex biological data into actionable insights \nKey topics include:\n~ Case study: using AI and metabolomics to overcome optimization plateaus\n~ Multi-omics approaches in cell culture development\n~ AI-enabled data integration and pattern recognition\n~ Understanding productivity and product quality trade-offs\n~ From biological data to development decisions \nDiscover how AI and multi-omics are helping developers move beyond descriptive analytics toward more predictive\, mechanism-based approaches to cell culture optimization.
URL:https://thebiocalendar.com/event/from-data-to-decisions-ai-and-multi-omics-for-cell-culture-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-13-26-Thermo-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T110000
DTEND;TZID=America/Los_Angeles:20260813T120000
DTSTAMP:20260725T055907Z
CREATED:20260721T175625Z
LAST-MODIFIED:20260725T055907Z
UID:10806-1786618800-1786622400@thebiocalendar.com
SUMMARY:When Unexpected Particles Threaten Your Biologic
DESCRIPTION:Unexpected particle findings can raise critical questions about product quality\, patient safety\, and regulatory compliance. \nJoin KBI Biopharma’s experts to learn how clinical in-use studies and advanced particle forensics can help identify particle sources\, assess risk\, and build regulator-ready evidence for confident decision-making. \nRegister now to discover practical strategies for accelerating investigations\, supporting development timelines\, and responding effectively when unexpected particles threaten your biologic.
URL:https://thebiocalendar.com/event/when-unexpected-particles-threaten-your-biologic/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-13-26-KBI-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T100000
DTEND;TZID=America/Los_Angeles:20260813T120000
DTSTAMP:20260630T200519Z
CREATED:20260629T132259Z
LAST-MODIFIED:20260630T200519Z
UID:10668-1786615200-1786622400@thebiocalendar.com
SUMMARY:Commercial Readiness Solutions
DESCRIPTION:The journey from a successful lab result to a reliable\, GMP-compliant product is rarely a straight line. It’s a transition filled with technical hurdles\, regulatory pressure\, and the constant challenge of scaling without compromise. \nWe created the Commercial Readiness Solutions session to help you navigate this transition. This virtual event is designed to be highly practical – moving past high-level theory to focus on the specific tools and partnerships needed to solve the real-world bottlenecks in your production lifecycle. \nJoin us to evaluate the solutions and technologies essential for a sustainable commercial platform\, including: \nGMP Execution & Inspection Readiness: Building the protocols and confidence to meet global regulatory standards.\nManufacturing Scale-up: Leveraging closed-system automation to reduce manual risk and variability.\nContamination Control: Implementing advanced strategies to ensure sterility and product safety at scale.\nQC & Release Testing: Optimizing testing strategies to accelerate the path from the facility to the patient.\nValidation & Data Integrity: Ensuring your process documentation is robust\, transparent\, and compliant.\nDigital Infrastructure: Integrating eQMS\, MES\, and LIMS for a seamless\, paperless manufacturing environment. \nPractical Insights\, Not Just Presentations. Through solution-focused sessions and real-world case studies\, this event will highlight the supplier capabilities and technologies that reduce risk and accelerate your timelines. Our goal is to show you how to strengthen your operational resilience – maintaining the highest quality standards without sacrificing the throughput you need to stay competitive. \nMove Forward with Confidence. Whether you are preparing for your next inspection\, refining your control strategy\, or building a repeatable platform for the global market\, we are here to connect you with the right expertise. Join us to find the tools and insights you need to move confidently from development to commercial success – bringing life-changing therapies to more patients\, faster.
URL:https://thebiocalendar.com/event/commercial-readiness-solutions/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/08-2026-CGTE-1280x720-COMMERCIAL-scaled.png
END:VEVENT
END:VCALENDAR